Armis announced a pre-IPO funding round of $435 million, bringing the company’s valuation to $6.1 billion. The round was led by Growth Equity at Goldman Sachs Alternatives with major participation fro...
Nano Cures, a clinical stage biotechnology and infectious disease immunity platform company, today announced a $90M pre-IPO funding round. The investment will be led by a $20M commitment from Opulence...